Navigation Links
Medivation Presents Positive New Data on Dimebon's Long-Term Efficacy and Novel Mechanism of Action at the International Conference on Alzheimer's Disease
Date:7/30/2008

SAN FRANCISCO, July 30 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN) today announced new data showing that its investigational drug Dimebon continues to produce broad, clinically meaningful benefits in Alzheimer's disease patients after long-term dosing, and appears to operate through a novel mechanism of action. These data were presented today in a podium session and two poster sessions at the 2008 Alzheimer's Association International Conference on Alzheimer's Disease (ICAD) in Chicago. The presentations are highlighted below.

Dimebon Preserves All Key Functions in Alzheimer's Patients for 18 Months in Open-Label Extension of First Pivotal Trial

New data from a six-month open-label extension of the 12-month placebo-controlled study of Dimebon in patients with mild-to-moderate Alzheimer's disease demonstrated that Dimebon continued to improve the clinical course of the disease. After 18 months of treatment, Dimebon preserved function in patients at their original levels upon entering the trial across all key aspects of Alzheimer's disease, specifically memory and thinking, behavior, activities of daily living and overall function. These results are noteworthy as untreated Alzheimer's patients progressively deteriorate over time in these areas. Dimebon remained well tolerated throughout the 18-month treatment period.

The open-label extension data were presented in a poster session by Jeffrey Cummings, M.D., Director of the Mary S. Easton Center for Alzheimer's Disease Research at UCLA. "To my knowledge, no other approved or investigational treatment has stabilized function across all facets of Alzheimer's disease for this length of time," said Dr. Cummings. "These data suggest that Dimebon may provide long
'/>"/>

SOURCE Medivation, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Medivation Announces Publication in The Lancet of Dimebon Pivotal Trial Results in Alzheimers Disease
2. Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntingtons Disease
3. Medivation to Host Conference Call at 5 p.m. EDT Monday to Discuss Top-Line Phase 2 Study Results in Huntingtons Disease
4. Medivation Initiates Second Pivotal Phase 3 Trial of Dimebon(TM) in Patients With Alzheimers Disease
5. Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients at 44th ASCO Annual Meeting
6. Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting
7. Medivations Dimebon(TM) Significantly Improved Thinking and Memory in Alzheimers Disease Patients Over One Year
8. Medivations Dimebon(TM) Significantly Improved Daily Function in Alzheimers Disease Patients, Resulting in Reduced Need for Caregiver Assistance
9. Medivations Dimebon(TM) Stabilizes Behavioral Symptoms in Alzheimers Disease Patients, Resulting in Reduced Caregiver Distress
10. Medivations MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial
11. Anavex presents neuroprotective effects of Anavex 1-41 at the International Conference on Alzheimers Disease 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... May 21, 2013 RenovoRx ( www.renovorx.com ) ... "Top Startup" Award at TiEcon 2013, the world,s largest ... team and quality of entrepreneurial ideas. RenovoRx was honored ... Santa Clara Convention Center. ... of the most enterprising startup companies across five verticals: ...
(Date:5/21/2013)... 2013 /PRNewswire-iReach/ -- The 2013 Pharma ChemOutsourcing Show slated ... greatest number of "Emerging" small molecule biotech company ... Alexay .  "No one saw this coming", ... show,s still 4 months away and we may end ... big surprise and great news for attendees". Thecurrent list ...
(Date:5/21/2013)... 21, 2013  IsoRay, Inc. (AMEX: ISR ... entered into an exclusive international distribution agreement with IASIS ... in Greece . IsoRay is a ... medical radioisotope applications for brain cancer, lung cancer, head ... IASIS Medical is ideally suited to ...
Breaking Medicine Technology:RenovoRx Named Winner of 2013 TiE50 "Top Startup" 2Emerging Pharma at ChemOutsourcing 2013 in Record Numbers for Upcoming September Show 2IsoRay Announces A New International Distributor For Greece 2IsoRay Announces A New International Distributor For Greece 3
... Chuck Wielgus, Executive Director of USA Swimming, was named ... ceremony held in conjunction with the Wound, Ostomy and ... Orleans, LA.  The Great Comebacks® Program, which provides support ... to ostomy surgery, annually honors outstanding individuals who are ...
... Four-time NASCAR Cup Series champion Jeff Gordon, known ... he is for his philanthropic activities and tireless support ... the Alabama tornado relief effort through the Jeff Gordon ... clothing for babies and children affected by the destruction. ...
Cached Medicine Technology:Great Comebacks® Program Recognizes National Award Winners 2Great Comebacks® Program Recognizes National Award Winners 3Great Comebacks® Program Recognizes National Award Winners 4Great Comebacks® Program Recognizes National Award Winners 5Sanofi Pasteur Donates Tdap Vaccine to Aid Storm Victims 2Sanofi Pasteur Donates Tdap Vaccine to Aid Storm Victims 3Sanofi Pasteur Donates Tdap Vaccine to Aid Storm Victims 4Sanofi Pasteur Donates Tdap Vaccine to Aid Storm Victims 5
(Date:5/21/2013)... Octo Consulting Group, an award-winning ... solutions to the Federal marketplace, has named Tracy ... the newly created role, Denny will be responsible ... firm’s business development function to include business development ... leading strategies to achieve the firm’s strategic growth ...
(Date:5/21/2013)... News) -- Aggressive treatment for prostate cancer may ... underlying medical conditions, a new study finds. ... and radioactive seed implants, can cause serious side ... bowel problems, explained researchers from the University of ... that older patients with slower growing forms of ...
(Date:5/21/2013)... A study of veterans at high risk for developing ... be highly effective in helping clinicians spot tiny lung ... indicate the earliest stages of the disease. LDCT uses ... conventional CT scan. , Results of the study will ... "Lung cancer is the leading cause of cancer-related death ...
(Date:5/21/2013)... In adults with chronic kidney disease (CKD), ... CKD progression and transplant failure. Now, a first-of-its-kind study ... University has found a possible similar effect in children ... , The study of 366 children aged 1 ... effect of secondhand smoke exposure in CKD, according to ...
(Date:5/21/2013)... , , TUESDAY, May 21 (HealthDay News) -- Finding early ... but a new study adds to a growing body ... may help spot the beginnings of disease in high-risk ... risk for lung cancer, 6 percent were found to ... biopsies to confirm the diagnosis. CT scans detect abnormalities ...
Breaking Medicine News(10 mins):Health News:Octo Consulting Group Appoints Tracy Denny as Vice President of Business Development 2Health News:Age, Other Illnesses May Make Prostate Cancer Treatment Unnecessary 2Health News:Low radiation scans help identify cancer in earliest stages 2Health News:Low radiation scans help identify cancer in earliest stages 3Health News:Exposure to Secondhand Smoke May Lead to Worsening of Pediatric Kidney Disease; Pediatric Nephrology Publishes Dayton Children’s, Johns Hopkins Joint Study 2Health News:Exposure to Secondhand Smoke May Lead to Worsening of Pediatric Kidney Disease; Pediatric Nephrology Publishes Dayton Children’s, Johns Hopkins Joint Study 3Health News:Study Supports Using Low-Dose CT Scans to Spot Early Lung Cancer 2Health News:Study Supports Using Low-Dose CT Scans to Spot Early Lung Cancer 3
... a senior citizen,s health, yet fewer than half of all seniors ... medical attention are far less likely to engage in any of ... their medications or getting a cane or walker that might ... UCLA Center for Health Policy Research. In the ...
... was true for males tying the knot with younger females, study ... men seven to nine years their junior could be upping their ... with a significantly younger guy raises a woman,s risk of death ... 12 issue of Demography . , Not that marrying much ...
... ... records between doctors is the latest expansion of the affiliation between The Mount Sinai Medical ... and most comprehensive ear, nose, and throat, allergy and audiology practice in the tri-state area. ... New York, NY (Vocus) ...
... Scientists at The Wistar Institute offer a new explanation for ... the reasons why melanoma remains the deadliest form of skin ... explain why melanoma cells behave like both conventional tumor cells ... May 14 issue of the journal Cell thatcontrary ...
... held promise for building new organs to replace damaged livers, ... is getting cells grown in a lab dish to form ... MIT-Harvard Division of Health Sciences and Technology (HST) have come ... encapsulating living cells in cubes and arranging them into 3-D ...
... will continue validating its ToxCast screening tool by ... GlaxoSmithKline, Sanofi-Aventis, and Merck. These drugs never entered ... levels of toxicity when the pharmaceutical companies conducted ... Food and Drug Administration as part of the ...
Cached Medicine News:Health News:Falls and follow-ups: Medical attention following a fall critical to senior health 2Health News:Women Who Marry Younger Men May Die Earlier 2Health News:Mount Sinai Medical Center and ENT & Allergy Associates, LLP Create First-Of-Its-Kind Physician Portal 2Health News:Mount Sinai Medical Center and ENT & Allergy Associates, LLP Create First-Of-Its-Kind Physician Portal 3Health News:Wistar scientists explain the persistence of melanoma through 'dynamic stemness' 2Health News:Wistar scientists explain the persistence of melanoma through 'dynamic stemness' 3Health News:Tissue engineers create a new way to assemble artificial tissues 2Health News:Tissue engineers create a new way to assemble artificial tissues 3Health News:Pharmaceutical companies provide EPA 100 drugs to help predict toxicity 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: